| 1 |
29435137 | Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer. | 2018 Jan 12 |
3 |
| 2 |
29959144 | Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells. | 2018 Oct 1 |
1 |
| 3 |
22310287 | Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. | 2013 Jan 3 |
3 |
| 4 |
19451593 | Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors. | 2009 May 15 |
2 |